The observed adverse prothrombotic effects in clinical studies may be attributed to other causes such as the use of catheters or underlying thromboembolic risk factors, and further research is needed to confirm an association between thrombosis and C1-INH use[38, 40]. The gene discussed is SERPING1; the disease is deep vein thrombosis.